Literature DB >> 18308807

Risperidone depot in the treatment of psychosis associated with multiple sclerosis -- a case report.

A Hussain1, S Belderbos.   

Abstract

There is insufficient evidence worldwide regarding the choice of an appropriate anti-psychotic agent in the treatment of psychosis associated with multiple sclerosis. This case report demonstrates the effective use of Risperidone depot.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18308807     DOI： 10.1177/0269881107083997

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN： 0269-8811            Impact factor:   4.153


  2 in total

1.  A literature-based assessment of concept pairs as a measure of semantic relatedness.

Authors:  T Elizabeth Workman; Graciela Rosemblat; Marcelo Fiszman; Thomas C Rindflesch
Journal:  AMIA Annu Symp Proc       Date:  2013-11-16

2.  Safety and acceptability of clozapine and risperidone in progressive multiple sclerosis: a phase I, randomised, blinded, placebo-controlled trial.

Authors:  Anne C La Flamme; David Abernethy; Dalice Sim; Liz Goode; Michelle Lockhart; David Bourke; Imogen Milner; Toni-Marie Garrill; Purwa Joshi; Eloise Watson; Duncan Smyth; Sean Lance; Bronwen Connor
Journal:  BMJ Neurol Open       Date:  2020-07-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.